Submission Info
Submit an abstract to be considered for E-Poster Display at the 13th Annual Pain Medicine Meeting. The top scored scientific abstracts will be scheduled as E-Poster Presentations in Moderated E-Poster Sessions.
For technical questions regarding your abstract submission and for any other queries, please contact the Meeting Organizer at asra-pm@kenes.com.
ABSTRACT PRESENTATION FEE
A $65 fee will be charged for each abstract accepted for presentation. This payment is non-refundable and covers fees for abstract presentation in the e-Poster format; printed posters are not accepted. Only abstracts by paid presenters will be included in the final program guide and meeting materials. In order to pay this fee, you are required to complete the meeting registration process. Meeting registration is refundable according to the meeting cancellation policy.
If the abstract Presenting Author is different than the participant registering and paying the submission fee please advise the Meeting Organizer at asra-pm@kenes.com.
PLEASE NOTE
- Only accepted Scientific Abstracts are eligible for consideration of Best of MeetingAbstracts and Resident Best of Meeting Abstracts Awards.
- The Scientific Committee reserves the right to re-categorize the abstract.
ONLINE SUBMISSION PROCESS OVERVIEW
All abstracts must be formally submitted via the online Abstract Submission System, in English, and be of a quality suitable for publication. There is no limit to the number of abstracts that may be submitted. A presenter is expected to attend the meeting and present the poster. Only abstracts of authors who have paid their registration fees in advance will be scheduled for presentation and included in the program. If an abstract was previously submitted to a different meeting it may still be submitted. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
Abstract Submission Deadline: July 8, 2014
Abstract Notifications Sent: August 20, 2014
SUBMISSION CONTENTS AND FORMAT
- Presenting Author’s Contact Details (the maximum number of authors including Presenting Author and Co-authors is 10)
- Co-Authors’ Contact Details
- Abstract Title (limited to 25 words in sentence format)
- Abstract Text (limited to 500 words, note that word count is affected when graphs/tables/images are added, see below)
- Abstract Content Sections
- Introduction
- Material and methods
- Results
- Discussion
- References
- Funding disclosure (including industry grants or third-party research funding)
- Personal conflicts of interest disclosure
- Financial or other relationships with a commercial interest producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients
- Self and/or spouse/partner
- Over last 12 months
- Company name(s) and nature of relationship
- honoraria/expenses
- consulting/advisory board
- funded research
- royalties/patent
- stock options
- equity position
- ownership/employee
- other (please specify)
- “Nothing to disclose” if none of the above
Tables The maximum number of tables allowed per abstract is 3. Each table should be smaller than 10 rows x 10 columns. Each row of the table will be counted as 10 words against the 500 word total.
Figures For upload a maximum of 2 figures are allowed. Each figure is counted as 10 words. The maximum file size of each figure is 500 KB. The maximum pixel size is 600(w) x 800(h) pixel. Only figures in JPG format may be uploaded. If the file size or pixel size is too large, the figure must be resized accordingly. All uploaded tables and figures must be placed into the abstract text.
DRAFT ABSTRACTS
The submission system allows storing abstracts as a draft in order to make changes. However, abstracts must be formally submitted before the deadline in order to be sent to review for inclusion in the scientific program.
AGREEMENT AND SUBMISSION
All abstract submitters must confirm the following upon submission:
- I affirm that I and all others listed as authors contributed substantively to the writing, review, and work described by this abstract, and further affirm that it was not prepared or written by anyone not listed as an author.
- I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
- Submission of the abstract constitutes my consent to print and/or electronic publication (e.g. meeting website, program, other promotions, etc.)
- The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content”) provided to ASRA and Kenes International (Hereafter: “The Organizers”). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. The Abstract Submitter grants the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.
- The Organizers reserve the right to remove from any publication an abstract which does not comply with the above.
- I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.
PATIENT AND/OR INSTITUTIONAL REVIEW BOARD (IRB) APPROVAL
Only work that has received proper patient and/or Institutional Review Board (IRB) approval, as necessary, will be accepted. A statement indicating that approval has been granted should be incorporated into the abstract.
Applicants are required to confirm that approval has been granted before abstract submission:
- I have obtained patient and/or Institutional Review Board (IRB) approval, as necessary.
- An Institutional Review Board (IRB) and/or Animal Use Committee have waived the requirement for their formal approval of the study.
COPYRIGHTED MATERIAL
Applicants must attest to the following:
- There are no copyrighted figures, images, or content in my abstract.
- I have obtained permission from the copyright owner, if necessary.
CONFLICT OF INTEREST DECLARATION
All abstract submissions and poster presentations must include both in writing and verbally:
- Funding disclosure (including industry grants or third-party research funding)
- Personal conflicts of interest disclosure
- Financial or other relationships with a commercial interest producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients
- Self and/or spouse/partner Over last 12 months
- Company name(s) and nature of relationship
- “Nothing to disclose” if none of the above
All content must adhere to the following:
- Balance, independence, objectivity, and scientific rigor
- Recommendations involving clinical medicine based on the best available evidence, with references
- Scientific research cited conforms to standards and protocols accepted by the scientific community
- No recommendations made that are known to be ineffective or associated with dangers that outweigh benefits
- No promotional content of a commercial entity (includes product names, photos, logos, company names, etc.)
- Use of scientific/generic names; if necessary, trade names of several companies should be used
Declaration and Confirmation
- I confirm all requirements and that disclosure information provided is accurate, complete, and will be disclosed to participants in writing (in abstract and on poster) and verbally at the beginning of any presentation made during the meeting.
REVIEW AND GRADING PROCESS
Abstracts are blind reviewed by at a minimum 3 committee members and are graded using a 5-to-1 scale, with 5 being “must accept” and one 1 being “must reject. The ASRA review committee performing the review is identified based on the abstract category.
Scientific Abstracts
- Research Committee
- Support from CME Committee (members of committee with expertise in each field), as necessary
Medically Challenging Cases
- Scientific/Education Planning Committee
The ASRA committee review and ranking of these submissions does not constitute peer review and should not be interpreted as such. Notification regarding the status (accepted for poster presentation or rejected) will be sent to the abstract author approximately two months prior to the meeting.
AWARDS
Best of Meeting Abstracts (Scientific Abstracts only)
The top 20 highest scoring Scientific Abstracts that have met ASRA requirements for IRB approval, declaration of conflict of interest, and ASRA membership will be sent to the Research Committee, which will select 3 Best of Meeting Abstracts. Best of Abstract winners are included in the Moderated Poster sessions and are also invited to give an oral presentation from the podium as part of the Excellence in ASRA Award Luncheon. Presenters have a maximum of 3-5 minutes and 5-7 slides for their presentation. Slides have to be sent to the Research Committee Chair 2 weeks prior to the meeting. A certificate is given to the winners and the abstracts are tagged with a ribbon in the E-Poster system. Best of Meeting Abstract recipients must be present to receive the award and participate in the above presentation activities. If a winner is unable to participate, an alternative award winner will be selected.
Resident/Fellow Best of Meeting Abstracts and Research Travel Award
Upon submission, resident/fellow submitters have the option of having their abstract considered for the Resident/Fellow Research Travel Award. The top 10 highest scoring resident/fellow Scientific Abstracts will be sent to the Research Committee Chair who will then select 3 to receive an award. The Resident/Fellow Best of Meeting and Research Travel Award recipients will be invited to give an oral presentation from the podium as part of the Resident and Fellow Education Program. Winners will also receive a travel award up to the $1,500 to reimburse airfare, up to two hotel nights, and up to two per diem payments (all of which must be documented by copy of applicable receipts). A certificate is given to the winners (mailed by the ASRA main office after the meeting) and the abstracts are tagged with a ribbon in the E-Poster system. Resident/Fellow Best of Meeting and Research Travel Award recipients must be present to receive the award and participate in the above presentation activities. If a winner is unable to participate, an alternative award winner will be selected.
Note: Membership in ASRA is not required to submit a scientific abstract or medically challenging case. However, only abstracts submitted by ASRA members will be considered for the Best of Meeting Abstract Awards and Resident/Fellow Best of Meeting Abstracts and Research Travel Awards.
PRESENTATION DURING MEETING
Eligibility
Only the abstracts of presenting authors registered and paid for the meeting will be included in the final program and will be available online to meeting participants. Only corresponding authors or other authors listed on the submitted abstract may present onsite during the meeting, on condition that they are registered to the meeting and that the Meeting Organizer has been advised of this prior to the Meeting. Investigators who have abstracts approved for presentation but fail to attend the meeting three years in a row will be prohibited from submitting abstracts for the following two years.
E-Poster Display
All abstracts accepted for poster presentation during the annual meeting will be available onsite each day using E-Poster technology. Multiple plasma screens will be available in a clearly identified viewing area. Posters will be grouped by category and subcategory. Best of Meeting Scientific Abstracts and Resident/Fellow Awards will be identified within the E-Poster system with a ribbon or other marker and will be showcased on a prominently placed screen. The E-Posters will not be formally/officially moderated or discussed. However, authors are requested to be available in the E-Poster area during the break times for those attendees who may want to ask questions. Early bird registration rates will be extended to these authors.
Moderated E-Poster Sessions (Scientific Abstracts only)
Upon submission, authors will have the option to indicate if they would like to be considered for oral presentation during the annual meeting. A selection of posters are chosen by the Research Committee for oral presentation during the Moderated Poster Sessions. The maximum number of moderated sessions will be determined by the Scientific/Education Planning Committee and Project Management team based on program organization and meeting space; ASRA will provide as many oral presentation opportunities as possible. The Research Committee will then determine the final number of presentations based on the quality of submitted abstracts. These sessions will be structured according to category and subcategory as much as possible. Posters will be moderated at various times by various moderators. 9 to 10 abstracts will be assigned per 90 minute session. Each presenter will be allocated maximum 10 minutes per poster (5 minutes presentation and 5 minutes discussion). Early bird registration rates will be extended to these authors.
AVAILABILITY AFTER THE MEETING
ASRA Society and/or Meeting Websites
Abstracts (as submitted for initial grading) will be included on the ASRA website with no pre-determined removal date. E-Posters will be available online to meeting participants only and removed 3 months after the meeting.
Regional Anesthesia and Pain Medicine Journal (RAPM) Listing (Scientific Abstracts Only)
Regional Anesthesia and Pain Medicine (RAPM) is ASRA’s official, journal, publishing peer-reviewed scientific and clinical studies. Scientific Abstracts presented during the annual meeting are listed in the journal with abstract title, author, and affiliation data only; full abstracts are not included in print, but will be posted on the ASRA website with a link to the RAPM journal website. Medically Challenging Cases will not be printed in the journal or available on the journal’s website. E-Posters will not be printed in the journal or maintained on the Society’s website beyond 3 months from the meeting date .
